Laminin peptide ameliorates brain injury by inhibiting leukocyte accumulation in a rat model of transient focal cerebral ischemia

Kiyoyuki Yanaka, Paul J. Camarata, Stephen R. Spellman, Amy P Skubitz, Leo T Furcht, Walter C Low

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Postischemic cerebral inflammation has been reported to contribute to ischemic brain damage. During inflammation, constituents of the extracellular matrix such as fibronectin and laminin are recognized by certain integrins or proteoglycans and play an important role in the cell adhesion process. The purpose of this study was to evaluate the efficacy of peptides derived from laminin on leukocyte accumulation, infarct size, and neurological outcome in rats subjected to 1 h of cerebral ischemia and 48 h of reperfusion. Forty- four animals were included in this study: transient ischemia without treatment (Group I), treatment with TG-1 peptide (Group II), GD-I peptide (Group III), and GD-6 peptide (Group IV). Group II showed a significant reduction of the leukocyte accumulation (p < 0.001) and infarct size (p = 0.015) when compared with Group I. The neurological grade of Group II was also significantly better than in Group I at 48 h after reperfusion (p = 0.012). Based on these data, which are the first to explore the therapeutic potential of this peptide in cerebral ischemia, laminin peptide may offer a novel therapeutic approach to allaying injury in ischemic stroke.

Original languageEnglish (US)
Pages (from-to)605-611
Number of pages7
JournalJournal of Cerebral Blood Flow and Metabolism
Volume17
Issue number6
DOIs
StatePublished - Jan 1 1997

Fingerprint

Transient Ischemic Attack
Laminin
Brain Injuries
Leukocytes
Peptides
Brain Ischemia
Reperfusion
Inflammation
Proteoglycans
Fibronectins
Cell Adhesion
Integrins
Extracellular Matrix
Ischemia
Stroke
Wounds and Injuries
Brain
Therapeutics

Keywords

  • Adhesion molecules
  • Cerebral ischemia
  • Laminin
  • Leukocytes
  • Reperfusion

Cite this

Laminin peptide ameliorates brain injury by inhibiting leukocyte accumulation in a rat model of transient focal cerebral ischemia. / Yanaka, Kiyoyuki; Camarata, Paul J.; Spellman, Stephen R.; Skubitz, Amy P; Furcht, Leo T; Low, Walter C.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 17, No. 6, 01.01.1997, p. 605-611.

Research output: Contribution to journalArticle

@article{d3997745b50c4829b36a0ec75e8196e1,
title = "Laminin peptide ameliorates brain injury by inhibiting leukocyte accumulation in a rat model of transient focal cerebral ischemia",
abstract = "Postischemic cerebral inflammation has been reported to contribute to ischemic brain damage. During inflammation, constituents of the extracellular matrix such as fibronectin and laminin are recognized by certain integrins or proteoglycans and play an important role in the cell adhesion process. The purpose of this study was to evaluate the efficacy of peptides derived from laminin on leukocyte accumulation, infarct size, and neurological outcome in rats subjected to 1 h of cerebral ischemia and 48 h of reperfusion. Forty- four animals were included in this study: transient ischemia without treatment (Group I), treatment with TG-1 peptide (Group II), GD-I peptide (Group III), and GD-6 peptide (Group IV). Group II showed a significant reduction of the leukocyte accumulation (p < 0.001) and infarct size (p = 0.015) when compared with Group I. The neurological grade of Group II was also significantly better than in Group I at 48 h after reperfusion (p = 0.012). Based on these data, which are the first to explore the therapeutic potential of this peptide in cerebral ischemia, laminin peptide may offer a novel therapeutic approach to allaying injury in ischemic stroke.",
keywords = "Adhesion molecules, Cerebral ischemia, Laminin, Leukocytes, Reperfusion",
author = "Kiyoyuki Yanaka and Camarata, {Paul J.} and Spellman, {Stephen R.} and Skubitz, {Amy P} and Furcht, {Leo T} and Low, {Walter C}",
year = "1997",
month = "1",
day = "1",
doi = "10.1097/00004647-199706000-00002",
language = "English (US)",
volume = "17",
pages = "605--611",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Laminin peptide ameliorates brain injury by inhibiting leukocyte accumulation in a rat model of transient focal cerebral ischemia

AU - Yanaka, Kiyoyuki

AU - Camarata, Paul J.

AU - Spellman, Stephen R.

AU - Skubitz, Amy P

AU - Furcht, Leo T

AU - Low, Walter C

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Postischemic cerebral inflammation has been reported to contribute to ischemic brain damage. During inflammation, constituents of the extracellular matrix such as fibronectin and laminin are recognized by certain integrins or proteoglycans and play an important role in the cell adhesion process. The purpose of this study was to evaluate the efficacy of peptides derived from laminin on leukocyte accumulation, infarct size, and neurological outcome in rats subjected to 1 h of cerebral ischemia and 48 h of reperfusion. Forty- four animals were included in this study: transient ischemia without treatment (Group I), treatment with TG-1 peptide (Group II), GD-I peptide (Group III), and GD-6 peptide (Group IV). Group II showed a significant reduction of the leukocyte accumulation (p < 0.001) and infarct size (p = 0.015) when compared with Group I. The neurological grade of Group II was also significantly better than in Group I at 48 h after reperfusion (p = 0.012). Based on these data, which are the first to explore the therapeutic potential of this peptide in cerebral ischemia, laminin peptide may offer a novel therapeutic approach to allaying injury in ischemic stroke.

AB - Postischemic cerebral inflammation has been reported to contribute to ischemic brain damage. During inflammation, constituents of the extracellular matrix such as fibronectin and laminin are recognized by certain integrins or proteoglycans and play an important role in the cell adhesion process. The purpose of this study was to evaluate the efficacy of peptides derived from laminin on leukocyte accumulation, infarct size, and neurological outcome in rats subjected to 1 h of cerebral ischemia and 48 h of reperfusion. Forty- four animals were included in this study: transient ischemia without treatment (Group I), treatment with TG-1 peptide (Group II), GD-I peptide (Group III), and GD-6 peptide (Group IV). Group II showed a significant reduction of the leukocyte accumulation (p < 0.001) and infarct size (p = 0.015) when compared with Group I. The neurological grade of Group II was also significantly better than in Group I at 48 h after reperfusion (p = 0.012). Based on these data, which are the first to explore the therapeutic potential of this peptide in cerebral ischemia, laminin peptide may offer a novel therapeutic approach to allaying injury in ischemic stroke.

KW - Adhesion molecules

KW - Cerebral ischemia

KW - Laminin

KW - Leukocytes

KW - Reperfusion

UR - http://www.scopus.com/inward/record.url?scp=0030796879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030796879&partnerID=8YFLogxK

U2 - 10.1097/00004647-199706000-00002

DO - 10.1097/00004647-199706000-00002

M3 - Article

C2 - 9236717

AN - SCOPUS:0030796879

VL - 17

SP - 605

EP - 611

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 6

ER -